Observational studySurgery today2026
Risks and outcomes of surgical site infection after minimally invasive colorectal surgery: a Japanese multicenter study.
Observational study in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeStudies evaluating the occurrence, risk factors, and prognostic impact of surgical site infection (SSI) after minimally invasive surgery (MIS) for colorectal cancer are limited.
methodsThis multicenter retrospective study reviewed 3276 consecutive patients who underwent curative MIS for colorectal cancer between 2016 and 2024. Patients were divided into those who experienced incisional/deep SSI (n = 71), organ/space SSI (n = 67), and no SSI (no-SSI, n = 3138). This cohort was further subdivided into colon and rectum groups, and we examined the clinicopathological background and risk factors using a logistic regression analysis and prognosis using a Cox proportional hazards analysis.
resultsIn colon cancer, blood loss was an independent predictor of incisional/deep SSI (odds ratio (OR) 1.745, p = 0.042) and organ/space SSI (OR 6.087, 95% CI, 1.319-28.087; p = 0.020). In rectal cancer, preoperative treatment was an independent predictor of incisional/deep SSI (OR 5.619, p < 0.001) and organ/space SSI (OR 2.552, p = 0.021). In pathological node-negative patients with colon cancer, RFS (5-year RFS; 76.4% vs. 27.2% vs. 82.6%, p < 0.001) and OS (5-year OS; 80.0% vs. 56.0% vs. 86.4%, p = 0.013) were worse in the organ/space SSI group.
conclusionsPreoperative treatment and blood loss are risk factors for SSI. Even after SSI, administering appropriate adjuvant chemotherapy may be important for improving the prognosis.
Indexed as
Identifiers
42201415What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.